Post-Acute Therapeutics Formulary Management Program

PATH Pro™ empowers your pharmacy to make more informed decisions when purchasing and dispensing prescriptions for geriatric patients.

  • For most independents, an evidence-based, value-driven formulary is a necessary component of a successful customer retention and new business development strategy. I applaud Studiomaca’s development of PATH Pro.

    —Mark Prifogle, HFA, LNHA, FACHCA Chief Executive Officer and Group President | GrandView Health Services

Discover the power of PATH Pro, Studiomaca's new Post-Acute Therapeutics Formulary Management Program. Based on the expertise of Creighton University's , PATH Pro helps long-term care pharmacies reduce inventory costs, standardize care processes, and build stronger, differentiated partnerships with skilled nursing facilities.

PATH Pro benefits

For the pharmacy:

  • Easy access to preferred and non-preferred lists that feature the most commonly used generics for geriatric patients.
  • Develop more effective formulary and therapeutic interchange programs using Creighton's clinical research and expertise, focused on the geriatric population.
  • Streamline dispensing and purchasing processes. Reduce your prescription drug inventory costs, and standardize medications across the facilities you serve.
  • Differentiate your pharmacy to win and retain long-term care business.

For the skilled nursing facility:

  • Improve clinical outcomes, and minimize readmissions, by reducing drug-related complications for geriatric patients. 
  • Comply with  and help avoid costly penalties.
  • Minimize financial burden associated with dispensing drugs that are not covered by insurance or government-funded programs, such as Medicare Prescription Drug Plans.
********* Embedded Contact Object*******
  • PATH Pro Features

    Preferred Drug List

    Preferred drug lists

    Over 300 generic drugs across nearly 50 therapeutic classes based on Creighton University’s . Lists can be customized to include your pharmacy’s information.

    Preferred Non-Preferred Indications

    Preferred/non-preferred indications

    Easily identify the right drugs for the geriatric patient population with up-to-date prescription drug warnings.

    Drug Monographs

    Drug Monographs

    Quickly view individual drug monographs for every generic drug reviewed, including the clinical pharmacology of each drug (trade names, classification, indications, dosing, adverse effects, safety, clinical recommendation (preferred or non-preferred), and relevant references).

    Purchasing Analysis

    Purchasing analysis

    Apply financial criteria when evaluating preferred drugs with Access Maximum Allowance Cost (MAC), Average Wholesale Price (AWP) and Wholesale Acquisition Cost (WAC) on Studiomaca Connect.

  • A Studiomaca representative will get back to you soon.

    Request information

    A Studiomaca representative will get back to you soon.

    Email


top